Analytical Data
-
Gene name
FLJ13052
- Application
-
Alternative Names
dJ283E3.1; FLJ13052; FLJ37724; NAD kinase; Nadk; NADK_HUMAN; Poly(P)/ATP NAD kinase; PPNK; RP1-283E3.6
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
O95544
-
Expression Region
1-446aa
-
AA Sequence
MEMEQEKMTMNKELSPDAAAYCCSACHGDETWSYNHPIRGRAKSRSLSASPALGSTKEFRRTRSLHGPCPVTTFGPKACVLQNPQTIMHIQDPASQRLTWNKSPKSVLVIKKMRDASLLQPFKELCTHLMEENMIVYVEKKVLEDPAIASDESFGAVKKKFCTFREDYDDISNQIDFIICLGGDGTLLYASSLFQGSVPPVMAFHLGSLGFLTPFSFENFQSQVTQVIEGNAAVVLRSRLKVRVVKELRGKKTAVHNGLGEKGSQAAGLDMDVGKQAMQYQVLNEVVIDRGPSSYLSNVDVYLDGHLITTVQGDGVIVSTPTGSTAYAAAAGASMIHPNVPAIMITPICPHSLSFRPIVVPAGVELKIMLSPEARNTAWVSFDGRKRQEIRHGDSISITTSCYPLPSICVRDPVSDWFESLAQCLHWNVRKKQAHFEEEEEEEEEG
-
Molecular Weight
74.8 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The FLJ13052 protein, a member of the extensive family of recombinant proteins, has emerged as a subject of interest due to its potential roles in various biological processes. Initially identified through cDNA sequencing efforts, FLJ13052 has been implicated in cellular functions such as signal transduction, cellular proliferation, and apoptosis. Its expression patterns in diverse tissue types hint at potential involvement in both normal physiological and pathological conditions, including cancer progression and immune responses. Given the increasing demand for novel therapeutic targets, researchers have made significant strides in characterizing FLJ13052, utilizing techniques such as recombinant DNA technology to facilitate the production of the protein in vitro. Studies focusing on the protein's structure and function have opened avenues for exploring its role in disease mechanisms and its potential as a biomarker or therapeutic target. Furthermore, understanding FLJ13052's interactions with other cellular components can shed light on its contribution to complex signaling pathways and disease states, thereby enhancing our overall comprehension of human health and disease. As a result, the continued exploration of FLJ13052 provides vital insights into its biological significance and potential applications in biotechnology and medicine.
